Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Diabetes|December 16, 2020
Specific NLRP3 Inhibition Protects Against Diabetes-Associated AtherosclerosisArpeeta Sharma, Judy S Y Choi, Nada Stefanovic, et al.
Diabetologia|December 4, 2009
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetesA Koïtka, Z Cao, P Koh, et al.
Frontiers in Physiology|June 26, 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney DiseaseAnna M D Watson, Eleanor A M Gould, Sarah C Moody, et al.
Diabetologia|December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout miceA M D Watson, A Soro-Paavonen, K Sheehy, et al.
Clinical Science (London, England : 1979)|August 28, 2012
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetesMona Sedeek, Alex Gutsol, Augusto C Montezano, et al.
Molecular Cancer Therapeutics|October 12, 2021
A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast CancerJiaojiao Deng, Sophia B Chernikova, Yuelong Wang, et al.
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 22, 2026
Mitochondrial Alterations and CKDJairo A Pinzon-Cortes, Phoom Narongkiatikhun, Long Yuan, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Diabetes|December 16, 2020
Specific NLRP3 Inhibition Protects Against Diabetes-Associated AtherosclerosisArpeeta Sharma, Judy S Y Choi, Nada Stefanovic, et al.
Diabetologia|December 4, 2009
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetesA Koïtka, Z Cao, P Koh, et al.
Frontiers in Physiology|June 26, 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney DiseaseAnna M D Watson, Eleanor A M Gould, Sarah C Moody, et al.
Diabetologia|December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout miceA M D Watson, A Soro-Paavonen, K Sheehy, et al.
Clinical Science (London, England : 1979)|August 28, 2012
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetesMona Sedeek, Alex Gutsol, Augusto C Montezano, et al.
Molecular Cancer Therapeutics|October 12, 2021
A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast CancerJiaojiao Deng, Sophia B Chernikova, Yuelong Wang, et al.
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 22, 2026
Mitochondrial Alterations and CKDJairo A Pinzon-Cortes, Phoom Narongkiatikhun, Long Yuan, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Pageof 19